360 related articles for article (PubMed ID: 14551238)
1. Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy.
Byrne JA; Grieve DJ; Bendall JK; Li JM; Gove C; Lambeth JD; Cave AC; Shah AM
Circ Res; 2003 Oct; 93(9):802-5. PubMed ID: 14551238
[TBL] [Abstract][Full Text] [Related]
2. Pressure overload-induced myocardial hypertrophy in mice does not require gp91phox.
Maytin M; Siwik DA; Ito M; Xiao L; Sawyer DB; Liao R; Colucci WS
Circulation; 2004 Mar; 109(9):1168-71. PubMed ID: 14981002
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II-dependent chronic hypertension and cardiac hypertrophy are unaffected by gp91phox-containing NADPH oxidase.
Touyz RM; Mercure C; He Y; Javeshghani D; Yao G; Callera GE; Yogi A; Lochard N; Reudelhuber TL
Hypertension; 2005 Apr; 45(4):530-7. PubMed ID: 15753233
[TBL] [Abstract][Full Text] [Related]
4. Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice.
Matsuno K; Yamada H; Iwata K; Jin D; Katsuyama M; Matsuki M; Takai S; Yamanishi K; Miyazaki M; Matsubara H; Yabe-Nishimura C
Circulation; 2005 Oct; 112(17):2677-85. PubMed ID: 16246966
[TBL] [Abstract][Full Text] [Related]
5. Involvement of the nicotinamide adenosine dinucleotide phosphate oxidase isoform Nox2 in cardiac contractile dysfunction occurring in response to pressure overload.
Grieve DJ; Byrne JA; Siva A; Layland J; Johar S; Cave AC; Shah AM
J Am Coll Cardiol; 2006 Feb; 47(4):817-26. PubMed ID: 16487851
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin preconditioning of the heart: evidence for redox signaling.
Das S; Engelman RM; Maulik N; Das DK
Cell Biochem Biophys; 2006; 44(1):103-10. PubMed ID: 16456238
[TBL] [Abstract][Full Text] [Related]
7. Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF.
Yamagishi S; Nakamura K; Ueda S; Kato S; Imaizumi T
Cell Tissue Res; 2005 Jun; 320(3):437-45. PubMed ID: 15846509
[TBL] [Abstract][Full Text] [Related]
8. Role of gp91phox-containing NADPH oxidase in the deoxycorticosterone acetate-salt-induced hypertension.
Fujii A; Nakano D; Katsuragi M; Ohkita M; Takaoka M; Ohno Y; Matsumura Y
Eur J Pharmacol; 2006 Dec; 552(1-3):131-4. PubMed ID: 17064681
[TBL] [Abstract][Full Text] [Related]
9. Effects of p38 MAPK Inhibitor on angiotensin II-dependent hypertension, organ damage, and superoxide anion production.
Bao W; Behm DJ; Nerurkar SS; Ao Z; Bentley R; Mirabile RC; Johns DG; Woods TN; Doe CP; Coatney RW; Ohlstein JF; Douglas SA; Willette RN; Yue TL
J Cardiovasc Pharmacol; 2007 Jun; 49(6):362-8. PubMed ID: 17577100
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II attenuates endothelium-dependent responses in the cerebral microcirculation through nox-2-derived radicals.
Girouard H; Park L; Anrather J; Zhou P; Iadecola C
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):826-32. PubMed ID: 16439707
[TBL] [Abstract][Full Text] [Related]
11. Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice.
Dikalova A; Clempus R; Lassègue B; Cheng G; McCoy J; Dikalov S; San Martin A; Lyle A; Weber DS; Weiss D; Taylor WR; Schmidt HH; Owens GK; Lambeth JD; Griendling KK
Circulation; 2005 Oct; 112(17):2668-76. PubMed ID: 16230485
[TBL] [Abstract][Full Text] [Related]
12. Role of gp91phox (Nox2)-containing NAD(P)H oxidase in angiogenesis in response to hindlimb ischemia.
Tojo T; Ushio-Fukai M; Yamaoka-Tojo M; Ikeda S; Patrushev N; Alexander RW
Circulation; 2005 May; 111(18):2347-55. PubMed ID: 15867174
[TBL] [Abstract][Full Text] [Related]
13. Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase.
Johar S; Cave AC; Narayanapanicker A; Grieve DJ; Shah AM
FASEB J; 2006 Jul; 20(9):1546-8. PubMed ID: 16720735
[TBL] [Abstract][Full Text] [Related]
14. Ets-1 is a critical transcriptional regulator of reactive oxygen species and p47(phox) gene expression in response to angiotensin II.
Ni W; Zhan Y; He H; Maynard E; Balschi JA; Oettgen P
Circ Res; 2007 Nov; 101(10):985-94. PubMed ID: 17872466
[TBL] [Abstract][Full Text] [Related]
15. Opposing roles of p47phox in basal versus angiotensin II-stimulated alterations in vascular O2- production, vascular tone, and mitogen-activated protein kinase activation.
Li JM; Wheatcroft S; Fan LM; Kearney MT; Shah AM
Circulation; 2004 Mar; 109(10):1307-13. PubMed ID: 14993144
[TBL] [Abstract][Full Text] [Related]
16. Role of NADPH oxidase in the brain injury of intracerebral hemorrhage.
Tang J; Liu J; Zhou C; Ostanin D; Grisham MB; Neil Granger D; Zhang JH
J Neurochem; 2005 Sep; 94(5):1342-50. PubMed ID: 16011743
[TBL] [Abstract][Full Text] [Related]
17. Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy.
Hingtgen SD; Tian X; Yang J; Dunlay SM; Peek AS; Wu Y; Sharma RV; Engelhardt JF; Davisson RL
Physiol Genomics; 2006 Aug; 26(3):180-91. PubMed ID: 16670255
[TBL] [Abstract][Full Text] [Related]
18. The contribution of Nox4 to NADPH oxidase activity in mouse vascular smooth muscle.
Ellmark SH; Dusting GJ; Fui MN; Guzzo-Pernell N; Drummond GR
Cardiovasc Res; 2005 Feb; 65(2):495-504. PubMed ID: 15639489
[TBL] [Abstract][Full Text] [Related]
19. Impact of regular physical activity on the NAD(P)H oxidase and angiotensin receptor system in patients with coronary artery disease.
Adams V; Linke A; Kränkel N; Erbs S; Gielen S; Möbius-Winkler S; Gummert JF; Mohr FW; Schuler G; Hambrecht R
Circulation; 2005 Feb; 111(5):555-62. PubMed ID: 15699275
[TBL] [Abstract][Full Text] [Related]
20. Vascular smooth muscle cell NAD(P)H oxidase activity during the development of hypertension: Effect of angiotensin II and role of insulinlike growth factor-1 receptor transactivation.
Cruzado MC; Risler NR; Miatello RM; Yao G; Schiffrin EL; Touyz RM
Am J Hypertens; 2005 Jan; 18(1):81-7. PubMed ID: 15691621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
